Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
Information
- DOI:
- https://doi.org/10.1002/14651858.CD002125.pub3Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 20 January 2010see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Gynaecology and Fertility Group
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Neil Johnson conceptualised the protocol and the review primarily, and carried out the search, selection of trials and risk of bias assessment as a first reviewer and first author in the first version of the review and as a second reviewer in the current update.
Sabine van Voorst conducted the current update by performing the search and selection of trials, risk of bias assessment as a first reviewer and author. Martin Sowter proofread the primary protocol, was available to resolve discrepancies for differences of opinion between the other authors and added content expertise to the discussion and conclusions during the first and updated version of this review.
Ben Willem Mol and Annika Strandell proofread the updated review and added content expertise to the discussion and conclusion.
Sources of support
Internal sources
-
University of Auckland, School of Medicine, Auckland, New Zealand.
External sources
-
No sources of support supplied
Declarations of interest
Two of the authors (MS and AS) have performed clinical studies assessing the interventions studied in this review (Sowter 1997;Strandell 1999), the latter being one of the included RCTs in this review.
Neil Johnson works as a gynaecologist at Auckland City Hospital (a public hospital) in the National Women's Minimal Access Surgery and Endometriosis Service. NJ is also a private gynaecologist with groups called Endometriosis Auckland and Repromed Auckland. Within the last 3 years NJ has received financial support to attend conferences or to arrange research meetings from the following companies: Organon, Serono, Schering and Device Technologies.
Sabine van Voorst at the time was a medical student of the faculty of Health, Medicine and Life Sciences of the University of Maastricht, the Netherlands. She is now a resident in Obstetrics and Gynaecology at the Reinier de Graaf Gasthuis in Delft, the Netherlands. She has no financial conflict of interest.
Annika Strandell is a gynaecologist at Kungälv Hospital, associate professor at the University of Gothenburg and employed at the regional center for Health Technology Assessment in Göteborg, Sweden. She was the principle investigator and co‐ordinator of the Scandinavian trial on salpingectomy for hydrosalpinges prior to IVF. She has no financial conflict of interest.
Acknowledgements
The authors acknowledge the helpful comments of those who have refereed this review and the authors of included trials who supplied additional information or data in the previous and current review, particularly Annika Strandell, Evangelos Makrakis, Herve Déchaud, Nahed Hammadieh and Vaeceslav Moshin . We wish to thank Jane Clarke, MDSG Managing Editor, and Marian Showell, MDSG Trials Search Coordinator. Stephan Bontekoe assisted with copy editing in RevMan 5.
Version history
| Published | Title | Stage | Authors | Version |
| 2020 Oct 22 | Surgical treatment for tubal disease in women due to undergo in vitro fertilisation | Review | Pedro Melo, Ektoras X Georgiou, Neil Johnson, Sabine F. Voorst, Annika Strandell, Ben Willem J Mol, Christian Becker, Ingrid E Granne | |
| 2010 Jan 20 | Surgical treatment for tubal disease in women due to undergo in vitro fertilisation | Review | Neil Johnson, Sabine van Voorst, Martin C Sowter, Annika Strandell, Ben Willem J Mol | |
| 2004 Jul 19 | Surgical treatment for tubal disease in women due to undergo in vitro fertilisation | Review | Neil Johnson, Sabine van Voorst, Martin C Sowter, Annika Strandell, Ben Willem J Mol | |
| 2001 Jul 23 | Surgical treatment for tubal disease in women due to undergo in vitro fertilisation | Review | Neil NP Johnson, W Mak, M C Sowter | |
Differences between protocol and review
The current updated review differs from the original protocol in primary outcomes and risk of bias assessment. Definitions of fertility outcomes are applied stricter as of the 2008 update, reflecting current thoughts on fertility outcome (Dias 2006; Clarke 2008). Current risk of bias assessment reflects the current opinion in assessing quality of studies (Higgins 2008).
